Across TCGA pan-cancer cohorts, OR2J2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR2J2’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where OR2J2 RNA is repressed in tumor relative to normal tissue. In most cancer types OR2J2 is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

UCEC and KIRC are the cancer types where OR2J2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR2J2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.155	.012	2	view →
KIRC	All	All	+0.003	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR2J2 RNA expression & survival · all OR2J2 data types